TNFRSF11B and diabetes mellitus: To the best of our knowledge, this is the first study to evaluate the effects of zinc supplementation in a chronic model of diabetes-induced bone loss (90 days) through the analysis of RANKL, OPG, OC, COL1A, MMP-2, and MMP-9 mRNA expression.